Navigation Links
PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director
Date:9/8/2009

LONDON, Sept. 8 /PRNewswire/ -- PriceSpective, a value strategy consultancy that provides pricing and reimbursement services to pharmaceutical and biotechnology companies, is pleased to announce that it has hired two senior experts for its UK office. Walter Colasante, as a Vice President, and Sophie Murdoch, as a Director, will help further strengthen PriceSpective's pricing and reimbursement expertise and expand its current offerings.

Colasante, who brings 20 years experience in healthcare, will contribute to PriceSpective's real world pricing and reimbursement knowledge and client guidance, and will enhance PriceSpective's forecasting and portfolio and risk management services. Reflective of PriceSpective's promise of active senior level project involvement, Colasante will be an immediate resource for clients.

Expanding PriceSpective's commercial and device expertise, Murdoch brings 12 years of pharmaceutical experience. Murdoch will play a key role in developing strategic guidance for clients that synchronizes pricing and commercial goals.

"With ever-increasing pressure on drug pricing and debates over healthcare reforms across the globe," said CEO Steve Slovick, "we are delighted to bring on two, outstanding senior-level experts whose unique and diverse experiences will ensure the continuation of high quality services to our clients in a dynamic marketplace. Meanwhile, UK-based partner Keiron Sparrowhawk said, "Walter and Sophie will be invaluable in the continued growth and expansion of PriceSpective, enabling us to further meet our clients' needs."

Previously, Colasante was the founder and Managing Director of Freelance Heath Services, which specialised in pharmaceutical forecasting, business analysis and intelligence, market access planning and epidemiology. Colasante's previous consulting experience includes serving as a General Manager at The Mattson Jack Group and as a Senior Engagement Director at IMS. Colasante has also worked in clinical development for Novartis, Allergan and BMS.

Previously, Murdoch was an Associate Director at BMS, where she was responsible for developing the EMEA commercialization strategy for IXEMPRA. Before BMS, Murdoch was a Global Associate Director Hydrofiber Franchise at ConvaTec, a Marketing Manager at SSL International, and an International Product Manager at Smith & Nephew.

About PriceSpective

PriceSpective is a management consulting firm specializing in innovative strategies to identify, capture and communicate value for companies in the biopharmaceutical arena. We are uniquely positioned to deliver expert guidance in integrated global pricing, reimbursement and market access strategy due to our depth of experience and the active engagement of our senior leadership.

Over the last year, PriceSpective has climbed from position #413 on Inc 500's list of 'Fastest Growing Private Companies in America' to # 174. PriceSpective has offices in Los Angeles, Philadelphia and London and has a global staff of 49 professionals.


'/>"/>
SOURCE PriceSpective
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PriceSpective Continues Global Expansion With New San Diego Office
2. iPierian Appoints Dr. Matthew J. Plunkett as Chief Financial Officer
3. Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research & Development
4. ERT Appoints New Associate Director of Business Development - Japan
5. NeurogesX Appoints New Board Director and Audit Committee Chairman
6. Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer
7. Eiger BioPharmaceuticals Appoints Paul Truex to Board of Directors
8. Nucleix Appoints Meirav Chovav Vice President of Strategic Affairs and to the Board of Directors
9. Spectral appoints new board member
10. Cellular Dynamics International Appoints Leroy Hood, M.D., Ph.D., and George Church, Ph.D., to its Scientific Advisory Board
11. China Sky One Medical, Inc. Appoints New Independent Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... April 27, 2016 , ... ... mobile devices with fingerprint recognition for secure access, voice recognition for hands-free communication, ... ways consumers are interacting with biometrics technology today. But if they asked ...
(Date:4/27/2016)... (PRWEB) , ... April 27, 2016 , ... ... (d/b/a Biohaven) is pleased to announce the appointment of John Tilton as Chief Commercial ... Executive Director and one of the founding commercial leaders responsible for the commercialization ...
(Date:4/27/2016)... ... 27, 2016 , ... A compact PET scanner called NuPETâ„¢ ... (Magnetic Resonance Imaging) in existing third-party MRI systems. PET and MRI are complementary ... subjects. Simultaneous PET/MRI imaging offers a solution to many challenges that face researchers ...
(Date:4/27/2016)... PARIS , April 27, 2016 ... system disorders, today announces the appointment of Catherine Moukheibir as ... succeed MedDay,s previous Chairman, Jean Jacques Garaud , who ... The change is effective immediately. Catherine started her ... Boston and London .  She ...
Breaking Biology Technology:
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
(Date:3/22/2016)... and SANDY, Utah , ... which operates the highest sample volume laboratory in ... Genomics and UNIConnect, leaders in clinical sequencing informatics and ... launch of a project to establish the informatics infrastructure ... NSO has been contracted by the Ontario ...
Breaking Biology News(10 mins):